Alyeska Investment Group, L.P. Adverum Biotechnologies, Inc. Transaction History

Alyeska Investment Group, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$9.26 - $14.36 $185,200 - $287,200	-20,000 Reduced 36.31%	35,080 $346,000
Q4 2020 Feb 16, 2021	SELL	$9.84 - $14.26 $4,339 - $6,288	-441 Reduced 0.79%	55,080 $597,000
Q3 2020 Nov 16, 2020	SELL	$10.3 - $21.64 $365,423 - $767,743	-35,478 Reduced 38.99%	55,521 $571,000
Q1 2018 May 15, 2018	BUY	$3.65 - $7.95 $332,146 - $723,442	90,999 New	90,999 $528,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.